Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month

Stock Market Today, Jan. 23: ImmunityBio Falls After Gaining Over 200% in a Month

ImmunityBio (NASDAQ:IBRX), an immunity-focused biotech, closed Friday’s session at $6.45, down 12.13%. The stock is still up 63.29% in the past five days and 207.14% in the past month. Trading volume reached 74.6 million shares, coming in about 238% above its three-month average of 22.1 million shares. ImmunityBio IPO'd in 2015 and has fallen 83% since going public.How the markets moved todayThe broader markets were relatively steady Friday, wit…

ImmunityBio (IBRX) stock slides after glioblastoma update — here’s what investors watch next week

New York, Jan 24, 2026, 07:11 (EST) — Market closed ImmunityBio (NASDAQ: IBRX) shares closed Friday 12.1% lower at $6.45, after fluctuating between $7.86 and $6.44 during the session. The cancer immunotherapy firm saw roughly 76 million shares change hands. The decline comes just before next week as Wall Street shows renewed interest: On Thursday, BTIG lifted its price target from $6 to $9 and kept a Buy rating. The firm pointed to a “meaningful…